Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03101423 |
|
Recruitment Status : Unknown
Verified August 2018 by Liang Bo, First Affiliated Hospital of Guangxi Medical University.
Recruitment status was: Active, not recruiting
First Posted : April 5, 2017
Last Update Posted : August 28, 2018
|
Sponsor:
First Affiliated Hospital of Guangxi Medical University
Information provided by (Responsible Party):
Liang Bo, First Affiliated Hospital of Guangxi Medical University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | December 31, 2019 |
| Estimated Study Completion Date : | December 31, 2019 |